Biocon Ltd. is a global biopharmaceutical company headquartered in Bangalore, India. The company was incorporated in 1978 and has a strong focus on biotechnology. Biocon's main objective is to improve patient outcomes by finding innovative approaches to treat diabetes, cancer, and autoimmune diseases. They offer a range of healthcare products, including generics, biosimilars, research services, and novel biologics. With a workforce of over 13,500 employees, Biocon combines science, creativity, and advanced therapy platforms to develop high-quality and affordable medicines. Their aim is to achieve health equity by making their specialty portfolio of medicines accessible to everyone, everywhere. Biocon is committed to investing in novel therapies for diabetes, oncology, and immunology, while also expanding their global reach and economies of scale. They have a robust pipeline and a strong presence in over 120 countries, providing life-saving therapies and relief to millions of patients.
Legal Address
20th K.M. Hosur Road,, , Electronics City
Bangalore; Karnataka;
Postal Code: 560100
Contact Details: Purchase the Biocon Ltd. report to view the information.
Website: http://www.biocon.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service